List of prohibited drugs in Uzbekistan

Prohibited drugs in Uzbekistan

In line with the Decree of the Cabinet of Ministers as of November 12, 2015, № 330 “About bringing in, taking out and transit of narcotic drugs and precursors through the territory of the Republic of Uzbekistan” there are endorsed the lists of narcotics, psychotropic drugs and precursors, which are subject to control in the country:

List of narcotic drugs, traffic of which is forbidden (List I);
List of narcotic drugs, traffic of which is limited (List II);
List of psychotropic substances, traffic of which is limited (List III);
List of precursors, traffic of which is limited (List IV).

The narcotic drugs, included to the List I are forbidden to bringing in to the territory of Uzbekistan.

The Statement on the order of transportation and use at the territory of Uzbekistan of narcotic drugs and psychotropic substances for treatment of transit passengers, endorsed by the decree of the Cabinet of Ministers as of October 29, 2003 №472 “About endorsement of statements, identifying the order of circulation of narcotics, psychotropic substances and precursors in the Republic of Uzbekistan” foresees the following:
Patients, who pass through (transfer) the territory of Uzbekistan, can carry narcotic drugs and psychotropic substances included to the List II and List III, which are the subject for state control in Uzbekistan, for treatment purposes:

Narcotic drugs, in quantities not exceeding the dose for consumption within seven days;
Psychotropic substances, not exceeding the dose for consumption within fifteen days.

Attachment № 2
To the Decree of the Cabinet of Ministers
As of November 12, 2015, № 330

LIST OF NARCOTIC DRUGS TRAFFIC OF WHICH IS FORBIDDEN IN THE REPUBLIC OF UZBEKISTAN (LIST I)

Allylprodine
Alphameprodine
Alphamethadol
Alpha-methylphentanyl
Alphamethylthiophentanyl
Alphaprodine
Alphacetylmethadol
Anileridine
Acetyl-alphamethylphentanyl
Acetyldihydrocodeine
Acetylated opium
Acetylcodeinum
Acetylmethadol
Acetorphine
BDB [B(3,4- methylendioxyphenyl)-2 butanamine]
Bezitramide
Benzethidine
Benzylmorphine
Beta-hydroxy-3-methylphentanyle
Beta-hydroxyphentanyle
Betameprodine
Betamethadol
Betaprodine
Betacetylmethadol
Bang (anasha, cannabis resin )
Heroin (diacetylmorphine)
Hydrocodone
Hydrocodone phosphate
N-hydroxy-MDA
Hydromorphinol
Hydromorphone
Desomorphine
Dexamphetamine
Diampromide
Dihydromorphine
Dimenoxadol
N-dimethyl amphetamine
Dimepheptanol
Dimethylthiambutene
Dioxaphetyl butyrate
Dipipanone
Difenoxin
Diethylthiambutene
DMA (d,L-dimethoxyalpha-methyl-phenyl-ethylamine)
DMHP (dimethylheptylpyran)
DMT (dimethyltryptamine)
DOB (d, L-2,5-dimethoxy-4-brom-amphetamine)
DOC (d,L-2,5-dimethoxy-4-chlor-amphetamine)
DOET (d,L-2,5-dimethoxy-4-ethyl-amphetamine)
Drotebanol
DET (N,N – diethyltryptamine)
Isomethadone
Cannabis, marihuana
Kat
Cathine (d- norpseudoephedrine)
Cathinone (1-alpha-aminoprogthyophen)
Ketobemidone
Clopitazene
Codoxime
Coca bush
Handmade drugs from ephedrine or from drugs, containing ephedrine
Handmade drugs from pseudoephedrine or from drugs containing pseudoephedrine
Levomethorphan
Levomoramide
Levorphanol
Levophenacylmorphan
Lysergic acid and its preparations, including d-Lysergide (LSD, LSD-25)
Coca leaf
Poppy straw
Cannabis oil (hashish oil)
MBDB [N-Methyl -1 – (3,4-methylendyoxiphenyl)-2 buthanamine)
МДА (tenamphetamine)(МОА)
MDMA (d,L-3,4-methylendioxy-N-alpha-dimethyl-phenyl-ethylamine)
Mecloqualone
Methaqualone
4-methylaminorex
Methylphenidate (ritaline)
3-monoacetylmorphine
6-monoacetylmorphine
Mescalin
Methadone (Phenadonum)
d-methadone
L-methadone
Methadone, intermediate product (4-cyano-2-dimethyl amino-4, 4-diphenyl butane)
Netazocine
Methamphetamine
Methyldesorphine
Метилднгидроморфип
3-methylthyophentanyle
3-methylphentanyle
N- methylephedrine
Metopon
Myrophine
Milk sap of various types of poppy, containing poppy alkaloids, included to the lists of narcotic drugs and narcotic substances
MMDA (2-methoxy-alpha-4-methyl 4,5-(methylendioxy)- phenetilamyn)
Moramide intermediate product (2-methyl-3-morpholine-1, 1 –diphenyl-propane-carbonic acid)
Morpheridine
Morphine methyl bromide and other pentavalent azotic derivative of morphine
Morphine-14-oxyde
MPPP (1-methyl-4-phenyl-4-piperidine propionate (ether)
Nicodicodine
Nicocodine
Nicomorphine
Norocymethadol
Norocodeine
Norlevorphanol
Normethadone
Normorphine
Norpipanone
Oxycodone
Oxymorphone
Opium (including medical one) – clotted juice of opium or oil poppy
Opium poppy, a plant of Papaver somniferum species
Oripavine
Para-fluorophentanyle (parafluorophentanyle)
Parahexyl
PEPAP (L-phenylethyl-4-phenyl-4-piperidinol acetate (ether))
Pethidine
Pethidine, intermediate product А (4-cyano-1-methyl-4-phenylpiperidine)
Piminodine
Fruit body (any part) of any species of fungi, containing psilocybin and (or) psilocyn
PMA (4-methoxy-alpha-methyl phenyl-ethyl amine)
Proheptazine
Properidine
Propiram
Psilocybin
Psilocin
Pacemethorphan
Racemoramide
Racemorphan
Rolicyclidine
2С-В (4-brome-2,5 – dimethoxyphenetylamine)
STP (DOM) [2-amino-1-(2,5-dimethoxyи-4-methyl) phenyl propane]
Thabacon
Tenocyclidine

Tetrahydrocannabinol (all isomers)
Thyophentanile
ТМА (d, L-3,4,5-trimethoxy-alpha-methylenphenyl-amine)
Phenadoxone
Phenazocine
Phenampromide
Phenamine
Phencyclidine
Phenomorphan
Phenoperidine
Pholcodine
Furethidine
Ecgonine
Poppy straw extract (concentrate of poppy straw)
N-Ethyl-MDA (d,L-Ethyl-alpha-methyl-3.4-(methyleldioxy)- phenetylamil
Ethylmethylthiambutene
Eticyclidine
Etoxeridine
Etonitazene
Etorphine
Etriptamine
Ephedrone
4-МТА – 1-[4-(methylthio)phenyl]propan-2-amine – C₁₀H₁₅NS
JWH-007 – (2-methyl- 1-pentyl- (naphthalene-1-yl)methanone – С₂₅Н₂₅NO
JWH-011 – (2-methyl-1-(methylhexyl)-1H-indol-3-yl)-1-naphthalenylmethanone – С₂₅Н₂₉NO
JWH-015 – (2-methyl-1-propyl- 1H-indole-3- yl )-1 naphthalenylmethanone – С₂₃Н₂₁NO
JWH-016 – (1-butyl-2-methyl-1H-indol-3-yl)-1-naphthalenyl- methanone – С₂₄Н₂₃NO
JWH-018 – Naphthalen-1yl-(1-pentylindol-3-yl)methanone – С₂₄Н₂₃NO
JWH-019 – (1-hexyl-1H-indol-3-yl)(1-naphthyl)methanone – С₂₅Н₂₅NO
JWH-020 – (1-heptyl-1H-indol-3-yl)-1-naphthalenyl-methanone – С₂₆Н₂₇NO
JWH-022 – Naphthalen-1yl-(1-pent-4-en-1-yl)-1H-indol-3-yl)methanone – С₂₄Н₂₁NO
JWH-030 – Naphthalen-1yl-(1-pentyl-1H-pyrrol-3-yl)methanone – С₂₀Н₂₁NO
JWH-031 – (1-hexyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone – С₂₁Н₂₃NO
JWH-072 – 1-naphthalenyl(1-propyl-1H-indol-3-yl)methanone – С₂₂Н₁₉NO
JWH-073 – Naphthalen-1yl-(1-butylindol-3-yl)methanone – С₂₃Н₂₁NO
JWH-081 – (4-methoxynaphthalen-1yl)(1-pentyl-1H-indol-3-yl)methanone – С₂₅Н₂₅NO₂
JWH-098 – (4-methoxy-1-naphthalenyl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone – С₂₆Н₂₇NO₂
JWH-122 – (4-methylnaphthalen-1yl)-(1-pentylindol-3-yl)methanone – С₂₅Н₂₅NO
JWH-133 – 3-(1,1-dimethylbutyl)-6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran – С₂₂Н₃₂O
JWH-145 – Naphthalen-1yl-(1-pentyl-5-phenyl-1H-pyrrol-3-yl)-methanone – С₂₆Н₂₅NO
JWH-164 – (7-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone – С₂₅Н₂₅NO₂
JWH-175 – 3-(1-naphthalenylmethyl)-1-pentyl-1H-indole – С₂₄Н₂₅N
JWH-182 – (1-pentylindol-3-yl)-(4-propylnaphthalen-1yl)methanone – С₂₇Н₂₉NO
JWH-200 – (1-(2-morpholin-4-ylethyl)-1H-indol-3-yl)-(naphthalen-1yl)methanone – С₂₅Н₂₄N₂O₂
JWH-203 – (2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone – C₂₁H₂₂ClNO
JWH-210 – (4-ethylnaphthalen-1-yl)-(1-pentylindol-3-yl)-methanone – С₂₆Н₂₇NO
JWH-234 – (7-ethyl-1-naphthalenyl)-(1-pentyl-1H-indol-3-yl)-methanone – С₂₆Н₂₇NO
JWH-249 – 2-(2-bromophenyl)-1-(1-pentyl-1H-indol-3yl)-ethanone – С₂₁Н₂₂BrNO
JWH-250 – 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone – С₂₂Н₂₅NO₂
JWH-251 – 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone – С₂₂Н₂₅NO
JWH-267 – (2-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone – С₂₅Н₂₅NO₂
JWH-302 – 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone – С₂₂Н₂₅NO₂
JWH-307 – (5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)-naphthalen-1-yl-methanone – С₂₆Н₂₄FNO
JWH-309 – 1-naphthalenyl(5-(1-naphthalenyl)-1-pentyl-1H-pyrrol-3-yl)-methanone – С₃₀Н₂₇NO
JWH-368 – (5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone – С₂₆Н₂₄FNO
JWH-369 – (5-(2-chlorophenyl)-1-pentyl-1H-pyrrol-3-yl)-1-naphthalenyl-methanone – С₂₆Н₂₄ClNO
JWH-370 – (5-(2- methylphenyl)-1-pentyl-1H-pyrrol-3-yl) 1-naphthalenyl-methanone – С₂₇Н₂₇NO
JWH-387 – (4-bromonaphtalen-1-yl)(1-pentyl-1H-indol-3-yl)-methanone – С₂₄Н₂₂BrNO
JWH-398 – (4-chloronaphtalen-1-yl)(1-pentyl-1H-indol-3-yl)-methanone – С₂₄Н₂₂ClNO
JWH-412 – (4-fluoronaphtalen-1-yl)(1-pentyl- 1H-indol-3-yl)-methanone – С₂₄Н₂₂FNO
AM-251 – (1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide – С₂₂Н₂₁Cl₂IN₄O
AM-630 – 1-(2-(morpholin-4-yl)ethyl)-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole – С₂₃Н₂₅IN₂O₃
AM-281 – (1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide – С₂₁Н₁₉Cl₂IN₄O₂
AM-694 – (1-(5-fluoropentyl)indol-3-yl)-(2-iodophenyl)methanone – С₂₀Н₁₉FINO
AM-679 – (2-iodophenyl)(1-pentyl-1H-indol-3-yl)methanone – С₂₀Н₂₀INO
AM-1220 – 1-((1-methylpiperidin-2yl)methyl)-1H-indol-3-yl)(naphthyl)methanone – С₂₆Н₂₆N₂O
AM-1235 – (1-(5-fluoropentyl)-6-nitro-1H-indol-3-yl)-1-naphthalenyl-methanone – С₂₄Н₂₁FN₂O₃
AM-1241 – (2-iodo-5-nitrophenyl)-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone – С₂₂Н₂₂IN₃O₃
AM-1248 – 1-adamantyl-(1-((1-methylpiperidin-2-yl)methyl)indol-3-yl)-methanone – С₂₆Н₃₄N₂O
AM-2201 – (1-(5-fluoropentyl)-1H-indol-3-yl)-(naphthalene-1-yl)-methanone – С₂₄Н₂₂FNO
AM-2232 – 5-(3-(1-naphthoyl)-1H-indol-1-yl)-pentanenitrile – С₂₄Н₂₀N₂O
AM-2233 – (2-iodophenyl)-(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone – С₂₂Н₂₃IN₂O
AM-3102 – N-((1R)-2-hydroxy-1-methylethyl-9Z-octadecenamide – С₂₁Н₄₁NO₂
ЕAM-2201 – (1-(5-fluoropentyl)-1H-indol-3-yl)-(4-ethyl-naphthalen-1-yl)-methanone – С₂₆Н₂₆FNO
МAM-2201 – 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole – С₂₅Н₂₄FNO
CP-47,497 – 2-((1S,3R)-3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)-phenol – С₂₁Н₃₄O₂
CP-55,940 – 2-((1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)-phenol – С₂₄Н₄₀O₃
CP-80633 – oxy)-methoxyphenyl)-tetrahydro-2-(1H)-pyrimidinone – С₁₈Н₂₄N₂O₃
RCS-4 – 4-methoxyphenyl-(1-pentyl-1H-indol-3-yl)-methanone – С₂₁Н₂₃NO₂
RCS-8 – 1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone – С₂₅Н₂₉NO₂
URB-754 – 6-methyl-2-((4-methylphenyl)amino)-1-benzoxazin-4-one – С₁₆Н₁₄N₂O₂
URB-597 – (3’-(aminocarbonyl)(1,1’-biphenyl)-3-yl)-cyclohexylcarbamate – С₂₀Н₂₂N₂O₃
URB-602 – (1,1’-biphenyl)-3-yl-carbamic acid, cyclohexyl ester – С₁₉Н₂₁NO₂
CB-13 – 1-naphthalenyl(4-(pentylox)-1-naphthalenyl)-methanone – С₂₆Н₂₄O₂
HU-210 – 3-(1,1’-dimethylheptyl)-6aR,7,10,10aR-terahydro-1-hydroxy-6,6’-dimethyl-6H-dibenzo(b,d)pyran-9-methanol – С₂₅Н₃₈O₃
HU-211 – 3-(1,1’-dimethylheptyl)-6aS,7,10,10aS-terahydro-1-hydroxy-6,6’-dimethyl-6H-dibenzo(b,d)pyran-9-methanol – С₂₅Н₃₈O₃
HU-308 – 4-(4-(1,1’-dimethylheptyl)-2,6-dimethoxyphenyl)-6,6-dimethyl-bicyclo(3,1,1)hept-2-ene-2 –methanol – С₂₇Н₄₂O₃
HU-331 – 3-hydroxy-2-((1R)-3-methyl-6-prop-1en-2-ylcyclohex-2-en-1-yl)-5-pentylcyclohexa-2,5-diene-1,4-dione – С₂₁Н₂₈O₃
UR-144 – (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethyl-cyclopropyl)-methanone – С₂₁Н₂₉NO
AKB- 48 – N- (adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide – С₂₃Н₃₁N₃O
STS-135 – 1-(5-fluoropentyl)-N-tricyclo(3,3,1,13,7)dec-1yl-1H-indole-3-carboxamide – С₂₄Н₃₁FN₂O
WIN-48,098 – (4-methoxyphenyl)-(2-methyl-1-(2-(4-morfolinyl)ethyl)-1H-indol-3-yl)-methanone – С₂₃Н₂₆N₂O₃
WIN-55,212-2 – (R)-(+)-(2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone – С₂₇Н₂₆N₂O₃
5FUR-144 – (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)-methanone – С₂₁Н₂₈FNO
CRA-13 – 1-Naphthalenyl(4-(pentyloxy)-1-naphthalenyl)-methanone – С₂₆Н₂₄O₂
Org 27569 – 5-chloro-3-ethyl-N-(2-(4-piperidin-1-ylphenyl)ethyl)-1H-indole-2-carboxamide – С₂₄Н₂₈ClN₃O
Org 27759 – N-(2-(4-(dimethylamino)phenyl)ethyl)-3-ethyl-5-fluoro-1H-indole-2-carboxamide – С₂₁Н₂₄FN₃O
Org 29647 – N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2-carboxamide – С₂₂Н₂₄ClN₃O
A-796,260 – 1-(2-morpholin-4-ylethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone – С₂₂Н₃₀N₂O₂
A-834,735 – (1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl) methanone – С₂₂Н₂₉NO₂
A-836,339 – N-(3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene)-2,2,3,3-tetramethylcyclopropane-carboxamide – С₁₆Н₂₆N₂O₂S
AB-005 – (1-((1-methyl-2-piperidinyl)methyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone – С₂₃Н₃₂N₂O
JTE-907 – N-(benzo(1,3)dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-carboxamide – С₂₄Н₂₆N₂O₆

Remark:
The control is spread to:
All drugs and substances indicated in the current list, regardless to brand-names (synonyms) they bear;
Isomers (if they are not definitely excluded) of narcotic drugs, indicated in this list, in cases when existence of such isomers is possible in the framework of the current chemical name;
Complex and simple ethers of narcotic drugs, indicated in this list;

Salts of all narcotic drugs, indicated in this list, if existence of these salts is possible;
The paragraph 6 is stated in the edition of the subparagraph b) p.1 of attachment № 2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan №315 as of 16.07.2003.
The preparations, which contain narcotic substances, indicated in this list, regardless to their quantity and presence of neutral components (water, amylum, sugar, sodium bicarbonate, talc etc.).
Paragraph 7 is introduced in agreement with the subparagraph b) p. 1 of attachment №2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan № 315 as of 16.07.2003.
In terms of combined pharmaceutical preparations containing except the main narcotic substance under control other components control is established individually through inclusion of this combined drug to the current list.
There are introduced changes to the attachment № 4 in accordance to subparagraph c) p.1 of the attachment № 2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan № 315 as of 16.07.2003.

Attachment № 4
To the Decree of the Cabinet of Ministers
As of July 31, 2000. № 293

THE LIST OF PSYCHOTROPIC SUBSTANCES TRAFFIC OF WHICH IS LIMITED IN THE REPUBLIC OF UZBEKISTAN (СПИСОК III)

Allobarbital *
Alprazolam*
Aminorex*
Aprophenum
Barbitalum*
Barbital sodium
Benzphetamine *
Bromazepam *
bromisoval
Butalbital*
Butobarbital*
Vinylbital*
Halazepam *
Galoksazolam*
Halothane
Dextroamphetamine
Delorazepam*
Diazepam*
Droperidol
Camazepam*
Ketazolam*
Ketamine
Clobazam*
Cloxazolam*
Clonazepam*
Clorazepate*
Клотиазепам*
Clonidine hydrochloride
Levomethamphetamine *
Lefetamine *
Loprazolam*
Lorazepam*
Lormetazepam*
Mazindol *
Medazepam*
Midazolam *
Mezocarb*
Meprobamat *
Methylphenobarbital *
Methyprylon *
Mefenorex*
Mephobarbital *

Natrii oxybutiratis
Nimetazepam*
Nitrazepam *
Nordazepam*
Oxazepam *
Оксазолам*
Nemoline*
Pentobarbital *
Pinazepam*
Pinradrole*
Pyrovalerone*
Prazenam*
Pseudoephedrine *
Racemate methamphetamine*
Secbutabarbital*
Temazepam *
Tetrazepam *
Thiopental sodium
Triazolam *
Trihexyphenidyl hydrochloride
Phenazepam
Phendimetrazine *
Fencamfamine *
Phenobarbital *
Pheniroperex*
Phentermine *
Phelrosydnine hydrochloride
Fludiazepam*
Flunitrazepam *
Flurazepam *
Chlordiazepoxide *
Cephedrinum
Cyclobarbital*
Estazolam *
Ethylamphetamine *
Ethyl loflazepat *
Ethinamate *
Ethchlorvynol *
Ephedrine hydrochloride

*) The drug is in the list of substances are under international control.

Combined pharmaceuticals of pseudoephedrine:
1. Capsules (paracetamol 0.25 g, pseudoephedrine hydrocholride 0.03 g, chlorpheniramine maleate 0.00625 g, dextromethorphane hydrobromide 0.01 g).
2. Capsules (paracetamol 0.25 g, pseudoephedrine hydrochloride 0.03 g, chlorampheniramine maleate 0.002 g, dextromethorphane hydrobromide 0.01 g).
3. Capsules (paracetamol 0,25 g, pseudoephedrine hydrochloride 0,03 g, doxylamine succinate 0.00625 g, dextromethorphane hydrobromide 0.01 g). Antiflu.
4. Powders (paracetamol 0.65 g, pseudoephedrine hydrochloride 0.06 g, dextromethorphane hydrobromide 0.02 g, chlorpheniramine maleate 0.004 g)
5. Powders (paracetamol 0.65 g, chlorampheniramine 0.004 g, pseudoephedrine hydrochloride 0.06g).Teraflu.
6. Syrup (paracetamol 0.0338 g/ml, pseudoephedrine hydrochloride 0.002 g/ml, dextromethorphane hydrobromide 0.001 g/ml).
7. Syrup (pseudoephedrine hydrochloride 0.03 g/5ml, triprolidine hydrochloride 0.000125 g/5ml).
Syrup (paracetamol 0.0338 g/5ml, псевдоэфедрина гидрохлорида 0,0202 г/5мл, декстрометорфана гидробромида 0,001 г/5мл).
9. Syrup-mixture (pseudoephedrine hydrochloride 0.03 g, Guaiphenesini hydrochloridi 0.1 g).
10. Solution for drinking (pseudoephedrine hydrochloride 0,08 g/5ml, bromhexine 0.004g/5ml).
11. Tablets (pseudoephedrine hydrochloride 0,06 g, triprolidine hydrochloride 0.0025 g).
12. Tablets (ibuprofen 0.2g, pseudoephedrine hydrochloride 0.03 g).
13. Tablets (pseudoephedrine hydrochloride 0.06 g, bromhexine 0.008g).

Remark:The control is spread to:

All drugs and substances indicated in the current list, regardless to brand-names (synonyms) they bear;
Isomers (if they are not definitely excluded) of narcotic drugs, indicated in this list, in cases when existence of such isomers is possible in the framework of the current chemical name;
Complex and simple ethers of narcotic drugs, indicated in this list;
Salts of all narcotic drugs, indicated in this list, if existence of these salts is possible;
The paragraph 6 is stated in the edition of the subparagraph b) p.1 of attachment № 2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan №315 as of 16.07.2003
The preparations, which contain psychotropic substances, indicated in this list, regardless to their quantity and presence of neutral components (water, amylum, sugar, sodium bicarbonate, talc etc.).
Paragraph 7 is introduced in agreement with the subparagraph b) p. 1 of attachment №2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan № 315 as of 16.07.2003.
In terms of combined pharmaceutical preparations containing except the main narcotic substance under control other components control is established individually through inclusion of this combined drug to the current list.
There are introduced changes to the attachment № 5 in accordance to subparagraph c) p.1 of the attachment № 2 to the Decree of the Cabinet of Ministers of the Republic of Uzbekistan № 315 as of 16.07.2003.